OraQuick HIV Self Test
Composition:
The OraQuick HIV test consists of the following components:
1. **Test Device**: A test strip or device that contains:
- **Antibodies**: Specific antibodies that bind to HIV-1 and HIV-2 antibodies present in the sample.
- **Control Line**: A line that indicates the test has been performed correctly.
- **Sample Pad**: Where the oral fluid or blood sample is applied.
2. **Buffer Solution**: A solution that helps to facilitate the reaction between the sample and the antibodies on the test device.
3. **Instructions for Use**: Detailed guidelines on how to perform the test, interpret results, and handle samples.
Indications:
The OraQuick HIV test is indicated for:
- Men who have sex with men (MSM)
- Individuals with multiple sexual partners
- People who inject drugs
- Individuals with a history of sexually transmitted infections (STIs)
- **HIV Screening**: It is used for the preliminary screening of individuals for HIV infection, particularly in settings where rapid results are needed.
- **High-Risk Populations**: Recommended for individuals at higher risk of HIV exposure, including:
- **Follow-Up Testing**: Positive results from the OraQuick test should be confirmed with a laboratory-based test for definitive diagnosis.
- **Public Health Initiatives**: Used in community outreach programs, testing events, and other public health initiatives aimed at increasing awareness and testing for HIV.
### Important Notes:
- The OraQuick test is not a substitute for clinical diagnosis or treatment.
- A negative result does not rule out HIV infection, especially if exposure occurred within the last 3 months.
- Individuals should be counseled on the importance of follow-up testing and safe practices.
Always refer to the specific product insert and guidelines provided by the manufacturer for detailed information and instructions.